These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 27583588)

  • 1. Community-acquired pneumonia: still a major burden of disease.
    Feldman C; Anderson R
    Curr Opin Crit Care; 2016 Oct; 22(5):477-84. PubMed ID: 27583588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Community-acquired pneumonia.
    Irfan M; Farooqi J; Hasan R
    Curr Opin Pulm Med; 2013 May; 19(3):198-208. PubMed ID: 23422417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe community-acquired pneumonia: current management and future therapeutic alternatives.
    Garnacho-Montero J; Barrero-García I; Gómez-Prieto MG; Martín-Loeches I
    Expert Rev Anti Infect Ther; 2018 Sep; 16(9):667-677. PubMed ID: 30118377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Community acquired bacterial pneumonia.
    Anevlavis S; Bouros D
    Expert Opin Pharmacother; 2010 Feb; 11(3):361-74. PubMed ID: 20085502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of new therapies for severe community-acquired pneumonia.
    Restrepo MI; Anzueto A
    Curr Opin Infect Dis; 2006 Dec; 19(6):557-64. PubMed ID: 17075331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real life management of community-acquired Pneumonia in adults in the Gulf region and comparison with practice guidelines: a prospective study.
    Mahboub B; Al Zaabi A; Al Ali OM; Ahmed R; Niederman MS; El-Bishbishi R
    BMC Pulm Med; 2015 Sep; 15():112. PubMed ID: 26424530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors in hospitalized community-acquired pneumonia: a retrospective study of a prospective observational cohort.
    Ito A; Ishida T; Tokumasu H; Washio Y; Yamazaki A; Ito Y; Tachibana H
    BMC Pulm Med; 2017 May; 17(1):78. PubMed ID: 28464807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe community-acquired pneumonia.
    Alvarez-Lerma F; Torres A
    Curr Opin Crit Care; 2004 Oct; 10(5):369-74. PubMed ID: 15385753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current treatment of community-acquired pneumonia.
    Liapikou A; Torres A
    Expert Opin Pharmacother; 2013 Jul; 14(10):1319-32. PubMed ID: 23663104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving outcomes in community-acquired pneumonia.
    Bender MT; Niederman MS
    Curr Opin Pulm Med; 2016 May; 22(3):235-42. PubMed ID: 26859379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of community-acquired pneumonia in adults: 2016 guideline update from the Dutch Working Party on Antibiotic Policy (SWAB) and Dutch Association of Chest Physicians (NVALT).
    Wiersinga WJ; Bonten MJ; Boersma WG; Jonkers RE; Aleva RM; Kullberg BJ; Schouten JA; Degener JE; van de Garde EMW; Verheij TJ; Sachs APE; Prins JM
    Neth J Med; 2018 Jan; 76(1):4-13. PubMed ID: 29380739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outpatient management of community-acquired pneumonia.
    Froes F; Pereira JG; Póvoa P
    Curr Opin Pulm Med; 2019 May; 25(3):249-256. PubMed ID: 30585861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guideline adherence for empirical treatment of pneumonia and patient outcome. Treating pneumonia in the Netherlands.
    Huijts SM; van Werkhoven CH; Boersma WG; Buijs J; Buunk G; Compaijen CJ; van Elde LJ; Gisolf JE; van der Kam R; Kluytmans JA; Kuipers BA; Mager JJ; Oppedijk B; Palmen F; Prins JM; van Reemst B; Silbermann MH; van Tiel FH; van der Wall E; van der Werf TS; Bonten MJ
    Neth J Med; 2013 Dec; 71(10):502-7. PubMed ID: 24394734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjunctive Systemic Corticosteroids for Hospitalized Community-Acquired Pneumonia: Systematic Review and Meta-Analysis 2015 Update.
    Horita N; Otsuka T; Haranaga S; Namkoong H; Miki M; Miyashita N; Higa F; Takahashi H; Yoshida M; Kohno S; Kaneko T
    Sci Rep; 2015 Sep; 5():14061. PubMed ID: 26374694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tools for outcome prediction in patients with community acquired pneumonia.
    Khan F; Owens MB; Restrepo M; Povoa P; Martin-Loeches I
    Expert Rev Clin Pharmacol; 2017 Feb; 10(2):201-211. PubMed ID: 27911103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe community-acquired pneumonia: validation of the Infectious Diseases Society of America/American Thoracic Society guidelines to predict an intensive care unit admission.
    Liapikou A; Ferrer M; Polverino E; Balasso V; Esperatti M; Piñer R; Mensa J; Luque N; Ewig S; Menendez R; Niederman MS; Torres A
    Clin Infect Dis; 2009 Feb; 48(4):377-85. PubMed ID: 19140759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severity assessment in community-acquired pneumonia.
    Ewig S; Schäfer H; Torres A
    Eur Respir J; 2000 Dec; 16(6):1193-201. PubMed ID: 11292126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Community-acquired pneumonia in the elderly: a practical guide to treatment.
    Lieberman D; Lieberman D
    Drugs Aging; 2000 Aug; 17(2):93-105. PubMed ID: 10984198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting ICU admission in community-acquired pneumonia: clinical scores and biomarkers.
    Fernandez JF; Sibila O; Restrepo MI
    Expert Rev Clin Pharmacol; 2012 Jul; 5(4):445-58. PubMed ID: 22943124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How to reduce antibiotic consumption for community-acquired pneumonia?
    Montassier E; Goffinet N; Potel G; Batard E
    Med Mal Infect; 2013 Feb; 43(2):52-9. PubMed ID: 23433607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.